Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10046482HBVENSG00000010671.18protein_codingBTKYesNo695Q06187
Q5JY90
TVIS10057601HBVENSG00000010671.18protein_codingBTKYesNo695Q06187
Q5JY90
TVIS30021024HIVENSG00000010671.18protein_codingBTKYesNo695Q06187
Q5JY90
TCGA Plot Options
Drug Information
GeneBTK
DrugBank IDDB14924
Drug NameRitlecitinib
Target IDBE0001284
UniProt IDQ06187
Regulation Typeinhibitor
PubMed IDs35210753; 27791347
CitationsRamirez-Marin HA, Tosti A: Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata. Drug Des Devel Ther. 2022 Feb 17;16:363-374. doi: 10.2147/DDDT.S334727. eCollection 2022.@@Telliez JB, Dowty ME, Wang L, Jussif J, Lin T, Li L, Moy E, Balbo P, Li W, Zhao Y, Crouse K, Dickinson C, Symanowicz P, Hegen M, Banker ME, Vincent F, Unwalla R, Liang S, Gilbert AM, Brown MF, Hayward M, Montgomery J, Yang X, Bauman J, Trujillo JI, Casimiro-Garcia A, Vajdos FF, Leung L, Geoghegan KF, Quazi A, Xuan D, Jones L, Hett E, Wright K, Clark JD, Thorarensen A: Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition. ACS Chem Biol. 2016 Dec 16;11(12):3442-3451. doi: 10.1021/acschembio.6b00677. Epub 2016 Nov 10.
GroupsApproved; Investigational
Direct Classification
SMILESC[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2
Pathways
PharmGKB
ChEMBLCHEMBL4085457